However, among the MMD group, individuals carrying the ε2 or ε4 alleles exhibited a higher incidence of cerebral microbleeds—an established biomarker of cerebral small vessel disease—suggesting that APOE variants may be linked to specific disease phenotypes or increased disease severity in MMD [12]. The gene discussed is APOE; the disease is cerebral microbleeds.